Casper Tind Hansen

Casper Tind Hansen has a diverse work experience in the biotech and pharmaceutical industries. Casper Tind is currently the CEO and co-founder of Embark Biotech ApS since December 2017. In January 2019, they took on the role of Chief Business Officer at Draupnir Bio. Prior to these positions, they were an Entrepreneur In Residence at BiOrigin ApS starting from June 2017. From April 2017 to December 2017, they served as the VP of Operations at IO Biotech ApS.

Before their involvement in various startups, Casper was the CEO of Pcovery, a biotech company specializing in anti-fungals, from March 2013 to May 2017. Casper Tind has also served as a board member at Adenium Biotech ApS from January 2012 to January 2015.

Casper began their career in the industry as a Principal at Novo A/S from August 2008 to February 2013. Prior to that, they worked as a Senior Market Analyst in Business Development and then as a Market Analyst and Medical Reviewer at H. Lundbeck A/S from 2004 to 2008. Casper Tind also had a brief stint as a Senior Market Analyst at Nycomed from November 2006 to July 2008. Overall, Casper Tind Hansen's work experience demonstrates their expertise in various roles within the biotech and pharmaceutical sectors.

Casper Tind Hansen earned their M.Sc. in Human Biology from the University of Copenhagen in 2003.